Stay updated on Tiragolumab Combo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.

Latest updates to the Tiragolumab Combo in Stage II Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s interface/update footer changed from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site version update. No clinical trial record details were shown to be added or removed in the displayed content.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision history now includes the addition of v3.4.3 and removal of v3.4.2.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded Revision: v3.4.2 to the record history. Removed the old funding notice and Revision: v3.4.1.SummaryDifference0.8%

- Check100 days agoChange DetectedAdded a site-wide notice about a lapse in government funding that may affect updates, processing, and responses, with guidance to check status. Updated the revision version to v3.4.1.SummaryDifference0.9%

Stay in the know with updates to Tiragolumab Combo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.